Giovanni Poli Selected Research

Giovanni Poli Research Topics

Disease

2	Hemorrhage 08/2017 - 06/2007
1	Celiac Disease (Celiac Sprue) 02/2021
1	COVID-19 12/2020
1	Hypertriglyceridemia 10/2019
1	Hyperbilirubinemia 10/2019
1	Hemolysis 10/2019
1	Anemia 10/2019
1	Dysbiosis 09/2019
1	Tangier Disease 08/2017
1	Inflammation (Inflammations) 03/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2011
1	Protein S Deficiency (Deficiency, Protein S) 07/2010
1	Activated Protein C Resistance (APC Resistance) 07/2010
1	Hyperhomocysteinemia 07/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2010
1	von Willebrand Diseases (von Willebrand's Disease) 10/2008
1	Acute-Phase Reaction 06/2007
1	Atrial Fibrillation 04/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2005
1	Lymphoma (Lymphomas) 11/2005
1	Neoplasms (Cancer) 11/2005
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2005

Drug/Important Bio-Agent (IBA)

2	von Willebrand FactorIBA 12/2020 - 06/2007
2	AntibodiesIBA 07/2010 - 11/2005
1	Nonesterified Fatty Acids (NEFA)IBA 02/2021
1	Butyric Acid (Butanoic Acid)IBA 02/2021
1	Interleukin-13IBA 12/2020
1	CytokinesIBA 12/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2020
1	ChemokinesIBA 12/2020
1	InterleukinsIBA 12/2020
1	InterferonsIBA 12/2020
1	Factor XII (Hageman Factor)IBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	Fibrinogen (Factor I)FDA Link 12/2020
1	Thrombin FDA Link 10/2019
1	Biological ProductsIBA 10/2019
1	Hemostatics (Antihemorrhagics)IBA 10/2019
1	CarbohydratesIBA 09/2019
1	Volatile Fatty AcidsIBA 09/2019
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	FHDIBA 08/2017
1	Adenosine Triphosphate (ATP)IBA 08/2017
1	AntioxidantsIBA 03/2011
1	SmokeIBA 03/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2011
1	Factor V (Coagulation Factor V)IBA 07/2010
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2010
1	Protein CIBA 07/2010
1	Prothrombin (Factor II)IBA 07/2010
1	AntithrombinsIBA 07/2010
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 07/2010
1	Protein SIBA 07/2010
1	factor V LeidenIBA 07/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2010
1	HomocysteineIBA 07/2010
1	AntigensIBA 10/2008
1	Blood Group Antigens (Blood Groups)IBA 06/2007
1	Warfarin (Coumadin)FDA LinkGeneric 04/2006
1	factor VII clotting antigenIBA 04/2006
1	Factor VIIa (Activated Factor VII)IBA 04/2006
1	Rituximab (Mabthera)FDA Link 11/2005

Therapy/Procedure

1	Therapeutics 04/2006
1	Drug Therapy (Chemotherapy) 11/2005